Table 2.
CTD-associated PAH
|
Idiopathic PAH (n = 1,654) | P, all CTD-associated PAH vs. idiopathic PAH | |||
---|---|---|---|---|---|
All (n = 716) | SSc-associated PAH (n = 407) | Non–SSc-associated PAH (n = 309) | |||
AE | |||||
Occurrence of at least 1 AE, % | 84 | 87 | 79 | 81 | 0.20 |
AEs per person, median (IQR) no. | 3 (1–7) | 3 (1–7) | 3 (1–6) | 3 (1–6) | 0.87 |
SAE | |||||
Occurrence of at least 1 SAE, % | 19 | 20 | 17 | 14 | <0.001 |
SAEs per person, % | <0.001 | ||||
0 | 81 | 80 | 83 | 86 | |
1 | 14 | 14 | 13 | 9 | |
>1 | 5 | 6 | 4 | 5 |
CTD-associated PAH = connective tissue disease–associated pulmonary arterial hypertension; SSc = systemic sclerosis; IQR = interquartile range.